Wego has provided $34m for Neurovasc in connection with a joint development agreement and clinical trials covering neurovascular disease treatments.

BlueCross BlueShield Venture Partners co-led a series C round for AxialHealthcare, developer of a medication-addiction mitigation platform.

MassMutual Ventures Southeast Asia was among the investors in a round that will fund Fractal Analytics spinoff Qure.ai's product development.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Access Industries and Eli Lilly-backed genetic drug developer floated at the top of its range having increased the number of shares in the offering by 60%.

Auriens-backed Cera boosted its overall funding to $91m as it seeks both domestic and international expansion for its home elderly care service.

Cyagen's Chinese research product spinoff raised $40.5m and will use the funding to grow its business along with its contract research services.

University of Pennsylvania-linked Passage Bio issued 4.6 million more shares than originally planned to raise $216m, up more than 70% on its $125m original target.

Stem cell medicine and skincare product developer has added $12.5m as part of a series B-2 round that will come after $15m from SFC two years ago.